论文部分内容阅读
目的：探索爱维治（Ａｃｔｏｖｅｇｉｎ）对脑动脉硬化性眩晕的疗效。方法：７８例以眩晕为主要表现的脑动脉硬化病人，其中４０例用爱维治注射液２０ｍＬ（含８００ｍｇ）与复方丹参注射液１６ｍＬ分别加入５％葡萄糖液２５０ｍＬ静脉滴注，ｑｄ，２ｗｋ为一个疗程。另３８例用复方丹参注射液１６ｍＬ加入５％葡萄糖液２５０ｍＬ静脉滴注，ｑｄ，２ｗｋ作为对照。结果：治疗组总有效率９３％，对照组为６１％（Ｐ＜０．０５）。结论：联用爱维治与复方丹参治疗脑动脉硬化性眩晕的疗效优于单用丹参。
Objective: To explore the effect of Actovegin on cerebral arteriosclerotic vertigo. Methods: A total of 78 patients with cerebral arteriosclerosis who had vertigo as the main symptom were enrolled in this study. In 40 cases, 20 mL of Averbia injection (including 800 mg) and compound Danshen injection (16 mL) were added to 250 mL of 5% glucose solution intravenously. A treatment. Another 38 cases with compound Danshen injection 16mL added 5% glucose 250mL intravenous infusion, qd, 2wk as a control. Results: The total effective rate was 93% in the treatment group and 61% in the control group (P <0.05). Conclusion: Combination of Aiweizhi and Fufang Danshen is superior to Salvia miltiorrhiza alone in the treatment of cerebral arteriosclerotic vertigo.